(Q38336352)

2 September 2017

title

Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease (English)

1 reference

2 September 2017

0 references

1 reference

Feng Hong

1

1 reference

2 September 2017

Svetlana Radaeva

2

1 reference

2 September 2017

Hong-na Pan

3

1 reference

2 September 2017

Zhigang Tian

4

1 reference

2 September 2017

Richard Veech

5

1 reference

2 September 2017

Bin Gao

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

2 September 2017

1 reference

2 September 2017

volume

40

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

933-941

1 reference

STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers

2 September 2017

cites work

1 reference

Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

21 January 2018

1 reference

Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning

21 January 2018

1 reference

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

7 January 2021

Update on nonalcoholic fatty liver disease

1 reference

7 January 2021

AGA technical review on nonalcoholic fatty liver disease

1 reference

7 January 2021

Non-alcoholic fatty liver disease: an overview

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Fatty liver in liver transplantation and surgery

1 reference

7 January 2021

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection

1 reference

7 January 2021

Cytokines in alcoholic liver disease

1 reference

7 January 2021

Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis

1 reference

7 January 2021

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

7 January 2021

Massive liver growth in mice induced by systemic interleukin 6 administration.

1 reference

7 January 2021

Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration

1 reference

7 January 2021

Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6

1 reference

7 January 2021

Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent

1 reference

7 January 2021

Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

1 reference

7 January 2021

Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases

1 reference

7 January 2021

Interleukin 6 is important for survival after partial hepatectomy in mice

1 reference

7 January 2021

Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins

1 reference

7 January 2021

Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

1 reference

7 January 2021

Lack of gp130 expression in hepatocytes promotes liver injury1 1K.L.S. and T.W. contributed equally to this work

1 reference

7 January 2021

Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway.

1 reference

7 January 2021

In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats

1 reference

7 January 2021

IL-6: a magic potion for liver transplantation?

1 reference

7 January 2021

Interleukin-6 stimulates hepatic triglyceride secretion in rats

1 reference

7 January 2021

Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway

1 reference

7 January 2021

Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes

1 reference

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice

1 reference

7 January 2021

A new and simple technique of total hepatic ischemia in the mouse

1 reference

7 January 2021

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

7 January 2021

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

1 reference

7 January 2021

Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype

1 reference

7 January 2021

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

1 reference

7 January 2021

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

1 reference

7 January 2021

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

1 reference

7 January 2021

Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis

1 reference

7 January 2021

Mechanisms of ischemic injury are different in the steatotic and normal rat liver

1 reference

7 January 2021

Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism

1 reference

7 January 2021

Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury

1 reference

7 January 2021

Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver

1 reference

7 January 2021

Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning

1 reference

7 January 2021

Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice

1 reference

7 January 2021

Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20400

1 reference

2 September 2017

1 reference